The Analyst Landscape: 11 Takes On Merit Medical Systems
Portfolio Pulse from Benzinga Insights
Merit Medical Systems (NASDAQ:MMSI) has been the subject of diverse analyst ratings over the last three months, with 11 analysts offering views that range from bullish to bearish. The recent ratings show a mix of 5 bullish, 5 somewhat bullish, and 1 indifferent, with an upward trend in the 12-month price target to an average of $93.45. Analyst actions include both raises and lowers in ratings and price targets, reflecting ongoing market conditions and company performance. Merit Medical Systems, a medical equipment company, has shown solid financial performance with a revenue growth rate of 10.6%, a net margin of 8.51%, and strong ROE and ROA figures.
May 01, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems has received a mix of analyst ratings, with an updated average 12-month price target of $93.45. The company's financial performance includes a 10.6% revenue growth and a net margin of 8.51%, indicating strong profitability and market confidence.
The mix of analyst ratings from bullish to indifferent, combined with the upward revision of the 12-month price target, suggests a positive outlook for MMSI in the short term. The company's solid financial performance, including significant revenue growth and a high net margin, further supports this positive impact. The confidence in this analysis is based on the detailed financial metrics and analyst actions provided, indicating a comprehensive understanding of the company's current market position and future potential.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100